Purchase Order 75D30118P00763
Award Date 4/27/18
Potential Completion Date 6/14/19
Potential Value $77K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The federal contract award, with ID 75D30120P07349, was granted by the Centers for Disease Control and Prevention (CDC) to the University of Victoria, operating as Advancement Services, a non-profit educational institution in Canada. The contract is for the assembly and annotation of poxvirus genome sequences, with a firm fixed price of $80,000.10 and a completion date of July 14, 2021. The contract does not have a set-aside designation. The University of Victoria has demonstrated expertise in...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Victoria, operating as Advancement Services, a non-profit educational institution located in Victoria, British Columbia, Canada. The contract has a ceiling value of $81,250.00 and is for performing poxvirus genome sequences. The University of Victoria has demonstrated expertise in delivering specialized scientific software and services to federal agencies, including...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $241,671.00 firm-fixed-price purchase order to the University of Victoria for ARDI analysis services. The contract does not have a set-aside designation. The University of Victoria, through its Advancement Services division, provides a range of software, research, and professional services to federal agencies including the Centers for Disease Control and Prevention (CDC). Past CDC contracts awarded...
- This is a $550,000 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to the Rector & Visitors of the University of Virginia (UVA), a public research university, for a CPE Risk Study. The contract has an ultimate completion date of September 29, 2017. UVA, which has extensive experience managing complex federally-funded projects, is not performing this contract under a set-aside program. The university frequently serves as both a prime contractor and...
- This is a federal contract award to the University of Washington (UW) by the Centers for Disease Control and Prevention (CDC) for $742,701.15. The contract, which does not have a set-aside designation, is for FY 2021 BAA TOPIC 8 - WASHINGTON and has an ultimate completion date of February 14, 2022. UW, a leading research university, is delivering viral genome sequencing and open-source software development services to support genetic epidemiology in Washington State through a subcontract with...
- This is a $4,096,310.00 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for COVID-19 genome sequencing services. The contract has an ultimate completion date of April 19, 2022. UW is a large public research university with extensive experience supporting federal agencies across various disciplines. The contract is not set aside for small businesses. UW has held several Indefinite Delivery Vehicles (IDVs) with the...
- This is a $1,224,290.00 Firm Fixed Price contract awarded by the Centers for Disease Control and Prevention (CDC) to Dalhousie University, a not-for-profit educational institution based in Halifax, Nova Scotia. The contract was awarded under the FY20 Broad Agency Announcement (BAA) Topic 5.1 and has a period of performance through August 31, 2024. The contract does not have a set-aside designation. As a research-intensive university, Dalhousie has a history of executing federal contracts and...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to The University of Queensland (UQ) in Australia. The $134,000 contract is for other functions and has no set-aside designation. UQ is a leading research institution in Australia that has been awarded multiple prime federal contracts and grants from U.S. government agencies, primarily for scientific research and development relevant to their missions. This...
- This is a $240,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to the University of Washington (UW) for EXOME SEQUENCING ANALYST SUPPORT services. The award has an ultimate completion date of April 21, 2025. UW is a large public research university that frequently competes for and wins federal contract and grant awards across various scientific and technological domains. This contract is not set aside. UW has significant experience providing...
- This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Virginia Commonwealth University (VCU) for the project "MICROBIOME DISRUPTION INDICES". The contract has a Firm Fixed Price structure and a ceiling value of $322,304.00. The period of performance ends on September 29, 2019. This award does not have a set-aside designation. VCU is a public research university that provides a wide range of services to the federal government, including...